Eastland continues its global expansion
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Secures rights to distribute new Anti-Malaria treatment
- Secures exclusive rights to distribute new silicone dressing
- Secures exclusive contract
- International Placement Agreement
- Eastland Secures Manufacturing
Later from Arovella Therapeutics
- Contracts to purchase South African Medical Device Man
- Eastland secures major interest in UK Listed Company
- Enters Letter of Intent with US Corporation
- Preliminary Final Report 30 June 2005
- Revenue Growth Forecasts
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics